Predictions
EssilorLuxottica SA
Start price
Target price
Perf. (%)
€157.25
29.07.22
29.07.22
€200.00
29.07.23
29.07.23
14.87%
30.07.23
30.07.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
Medtronic plc
Start price
Target price
Perf. (%)
€91.39
27.07.22
27.07.22
€100.00
27.07.23
27.07.23
-11.48%
28.07.23
28.07.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
Fresenius Medical Care AG & Co KGaA ST
Start price
Target price
Perf. (%)
€44.85
27.07.22
27.07.22
€60.00
27.07.23
27.07.23
5.35%
27.07.23
27.07.23
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Innovative
High dividend yield expected
EssilorLuxottica SA
Start price
Target price
Perf. (%)
€146.15
15.07.22
15.07.22
€175.00
15.07.23
15.07.23
21.16%
16.07.23
16.07.23
Becton, Dickinson & Co.
Start price
Target price
Perf. (%)
€235.25
13.07.22
13.07.22
€239.00
13.07.23
13.07.23
-1.59%
13.07.23
13.07.23
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€471.15
17.05.22
17.05.22
-
17.05.23
17.05.23
-6.19%
17.05.23
17.05.23
Thermo Fisher Scientific Inc.
Start price
Target price
Perf. (%)
€476.00
07.09.21
07.09.21
€550.00
31.12.23
31.12.23
4.08%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Thermo Fisher Scientific Inc.
Start price
Target price
Perf. (%)
€551.50
07.09.22
07.09.22
€700.00
31.12.25
31.12.25
-10.44%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Intuitive Surgical Inc
Start price
Target price
Perf. (%)
€233.45
25.04.22
25.04.22
€250.00
25.04.23
25.04.23
14.61%
26.04.23
26.04.23
Could be worthwhile Investment >10% per year
Fair valuation
Some uniques
Higher risks for its business
Sartorius Stedim Biotech S.A.
Start price
Target price
Perf. (%)
€328.00
20.02.22
20.02.22
€400.00
20.02.23
20.02.23
1.01%
21.02.23
21.02.23
Could be worthwhile Investment >10% per year
Coloplast A/S B
Start price
Target price
Perf. (%)
€115.40
16.01.23
16.01.23
€150.00
16.01.24
16.01.24
-0.26%
02.02.23
02.02.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Future proof or reliable business model
Intuitive Surgical Inc
Start price
Target price
Perf. (%)
€246.90
30.01.22
30.01.22
€270.00
30.01.23
30.01.23
-9.98%
31.01.23
31.01.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€407.05
24.01.22
24.01.22
€418.00
24.01.23
24.01.23
10.66%
25.01.23
25.01.23
Could be worthwhile Investment >10% per year
Fresenius Medical Care AG & Co KGaA ST
Start price
Target price
Perf. (%)
€29.85
13.11.22
13.11.22
-
13.12.22
13.12.22
1.61%
14.12.22
14.12.22
Known brand
Could be worthwhile Investment >10% per year
Carl Zeiss Meditec AG
Start price
Target price
Perf. (%)
€163.60
05.12.21
05.12.21
€180.00
05.12.22
05.12.22
-21.45%
06.12.22
06.12.22
Could be worthwhile Investment >10% per year
bioMerieux S.A.
Start price
Target price
Perf. (%)
€106.50
08.11.21
08.11.21
€110.00
08.11.22
08.11.22
-12.21%
09.11.22
09.11.22
Could be worthwhile Investment >10% per year
Carl Zeiss Meditec AG
Start price
Target price
Perf. (%)
€179.00
06.11.21
06.11.21
-
06.11.22
06.11.22
-32.77%
07.11.22
07.11.22
Koninklijke Philips Electronics
Start price
Target price
Perf. (%)
€13.13
02.11.22
02.11.22
-
02.11.23
02.11.23
-7.19%
03.11.22
03.11.22
Could be worthwhile Investment >10% per year
Koninklijke Philips Electronics
Start price
Target price
Perf. (%)
€15.79
27.09.22
27.09.22
€12.00
27.09.23
27.09.23
-0.06%
01.10.22
01.10.22
Henry Schein Inc.
Start price
Target price
Perf. (%)
€67.50
29.09.21
29.09.21
€65.00
29.09.22
29.09.22
0.87%
30.09.22
30.09.22
Could be worthwhile Investment >10% per year
Fresenius Medical Care AG & Co KGaA ST
Start price
Target price
Perf. (%)
€36.50
22.08.22
22.08.22
€66.00
22.08.23
22.08.23
-8.22%
03.09.22
03.09.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation